Sotera Health (NASDAQ:SHC) Shares Purchased by Victory Capital Management Inc.

Victory Capital Management Inc. grew its position in shares of Sotera Health (NASDAQ:SHCFree Report) by 25.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 32,610 shares of the company’s stock after purchasing an additional 6,666 shares during the period. Victory Capital Management Inc.’s holdings in Sotera Health were worth $545,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. CWM LLC boosted its position in Sotera Health by 86.1% in the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after buying an additional 993 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Sotera Health by 125.0% in the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock valued at $50,000 after purchasing an additional 1,660 shares during the last quarter. Point72 DIFC Ltd grew its stake in Sotera Health by 556.6% during the 2nd quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock valued at $78,000 after purchasing an additional 5,544 shares in the last quarter. Capital Performance Advisors LLP purchased a new stake in Sotera Health during the 3rd quarter worth approximately $91,000. Finally, Acadian Asset Management LLC raised its position in shares of Sotera Health by 728.0% in the 2nd quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock valued at $111,000 after purchasing an additional 8,248 shares in the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Stock Performance

Shares of NASDAQ SHC opened at $13.10 on Friday. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The firm’s 50-day moving average price is $15.32 and its two-hundred day moving average price is $14.00. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.44. The stock has a market capitalization of $3.71 billion, a P/E ratio of 52.40 and a beta of 2.08.

Sotera Health (NASDAQ:SHCGet Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company had revenue of $285.47 million for the quarter, compared to analyst estimates of $278.64 million. During the same quarter in the prior year, the firm earned $0.18 EPS. The company’s revenue for the quarter was up 8.5% compared to the same quarter last year. As a group, sell-side analysts forecast that Sotera Health will post 0.61 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on SHC. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a report on Thursday, November 21st. Citigroup increased their price target on shares of Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Finally, Barclays boosted their price objective on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $16.50.

Check Out Our Latest Analysis on Sotera Health

Insider Buying and Selling

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the transaction, the director now directly owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. The trade was a 16.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 55.12% of the company’s stock.

Sotera Health Profile

(Free Report)

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Featured Articles

Institutional Ownership by Quarter for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.